PubMed:32794723
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 278-295 | Body_part | denotes | respiratory tract | http://purl.org/sig/ont/fma/fma265130 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 278-295 | Body_part | denotes | respiratory tract | http://purl.obolibrary.org/obo/UBERON_0000065 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 64-72 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T2 | 211-223 | Disease | denotes | tuberculosis | http://purl.obolibrary.org/obo/MONDO_0018076 |
T3 | 248-258 | Disease | denotes | infectious | http://purl.obolibrary.org/obo/MONDO_0005550 |
T4 | 278-306 | Disease | denotes | respiratory tract infections | http://purl.obolibrary.org/obo/MONDO_0024355 |
T5 | 552-560 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T6 | 837-845 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T7 | 1051-1059 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 44-47 | Chemical | denotes | BCG | http://purl.obolibrary.org/obo/CHEBI_41001 |
T2 | 391-394 | Chemical | denotes | BCG | http://purl.obolibrary.org/obo/CHEBI_41001 |
T3 | 663-666 | Chemical | denotes | BCG | http://purl.obolibrary.org/obo/CHEBI_41001 |
T4 | 790-793 | Chemical | denotes | BCG | http://purl.obolibrary.org/obo/CHEBI_41001 |
T5 | 939-942 | Chemical | denotes | BCG | http://purl.obolibrary.org/obo/CHEBI_41001 |
T6 | 997-1005 | Chemical | denotes | antigens | http://purl.obolibrary.org/obo/CHEBI_59132 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 453-466 | http://purl.obolibrary.org/obo/GO_0045087 | denotes | innate immune |
T2 | 500-515 | http://purl.obolibrary.org/obo/GO_0045087 | denotes | innate immunity |
T3 | 1027-1042 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune response |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1 | 64-74 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
12 | 80-104 | Species | denotes | Bacillus Calmette-Guerin | Tax:33892 |
13 | 191-196 | Disease | denotes | death | MESH:D003643 |
14 | 211-223 | Disease | denotes | tuberculosis | MESH:D014376 |
15 | 278-306 | Disease | denotes | respiratory tract infections | MESH:D012141 |
16 | 311-326 | Disease | denotes | neonatal sepsis | MESH:D000071074 |
17 | 552-560 | Disease | denotes | COVID-19 | MESH:C000657245 |
18 | 581-587 | Disease | denotes | deaths | MESH:D003643 |
19 | 837-845 | Disease | denotes | COVID-19 | MESH:C000657245 |
20 | 911-958 | Species | denotes | Mycobacterium bovis (strain BCG/Pasteur 1173P2) | Tax:410289 |
21 | 1051-1061 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 278-306 | Phenotype | denotes | respiratory tract infections | http://purl.obolibrary.org/obo/HP_0011947 |
T2 | 311-326 | Phenotype | denotes | neonatal sepsis | http://purl.obolibrary.org/obo/HP_0040187 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-75 | Sentence | denotes | Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2. |
T2 | 76-158 | Sentence | denotes | The Bacillus Calmette-Guerin vaccine is still widely used in the developing world. |
T3 | 159-327 | Sentence | denotes | The vaccination prevents infant death not only from tuberculosis but also from unrelated infectious agents, especially respiratory tract infections and neonatal sepsis. |
T4 | 328-517 | Sentence | denotes | It is proposed that these off-target protective effects of the BCG vaccine are mediated by the general long-term boosting of innate immune mechanisms, also termed "trained innate immunity". |
T5 | 518-846 | Sentence | denotes | Recent studies indicate that both COVID-19 incidence and total deaths are strongly associated with the presence or absence of national mandatory BCG vaccination programs and encourage the initiation of several clinical studies with the expectation that revaccination with BCG could reduce the incidence and severity of COVID-19. |
T6 | 847-1062 | Sentence | denotes | Here, presented results from the bioinformatics analysis of the Mycobacterium bovis (strain BCG/Pasteur 1173P2) proteome suggests four immunodominant antigens that could induce an immune response against SARS-CoV-2. |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-75 | Sentence | denotes | Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2. |
T2 | 76-158 | Sentence | denotes | The Bacillus Calmette-Guerin vaccine is still widely used in the developing world. |
T3 | 159-327 | Sentence | denotes | The vaccination prevents infant death not only from tuberculosis but also from unrelated infectious agents, especially respiratory tract infections and neonatal sepsis. |
T4 | 328-517 | Sentence | denotes | It is proposed that these off-target protective effects of the BCG vaccine are mediated by the general long-term boosting of innate immune mechanisms, also termed "trained innate immunity". |
T5 | 518-846 | Sentence | denotes | Recent studies indicate that both COVID-19 incidence and total deaths are strongly associated with the presence or absence of national mandatory BCG vaccination programs and encourage the initiation of several clinical studies with the expectation that revaccination with BCG could reduce the incidence and severity of COVID-19. |
T6 | 847-1062 | Sentence | denotes | Here, presented results from the bioinformatics analysis of the Mycobacterium bovis (strain BCG/Pasteur 1173P2) proteome suggests four immunodominant antigens that could induce an immune response against SARS-CoV-2. |
T1 | 0-75 | Sentence | denotes | Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2. |
T2 | 76-158 | Sentence | denotes | The Bacillus Calmette-Guerin vaccine is still widely used in the developing world. |
T3 | 159-327 | Sentence | denotes | The vaccination prevents infant death not only from tuberculosis but also from unrelated infectious agents, especially respiratory tract infections and neonatal sepsis. |
T4 | 328-517 | Sentence | denotes | It is proposed that these off-target protective effects of the BCG vaccine are mediated by the general long-term boosting of innate immune mechanisms, also termed "trained innate immunity". |
T5 | 518-846 | Sentence | denotes | Recent studies indicate that both COVID-19 incidence and total deaths are strongly associated with the presence or absence of national mandatory BCG vaccination programs and encourage the initiation of several clinical studies with the expectation that revaccination with BCG could reduce the incidence and severity of COVID-19. |
T6 | 847-1062 | Sentence | denotes | Here, presented results from the bioinformatics analysis of the Mycobacterium bovis (strain BCG/Pasteur 1173P2) proteome suggests four immunodominant antigens that could induce an immune response against SARS-CoV-2. |
mondo_disease
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 64-74 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T2 | 211-223 | Disease | denotes | tuberculosis | http://purl.obolibrary.org/obo/MONDO_0018076 |
T3 | 248-258 | Disease | denotes | infectious | http://purl.obolibrary.org/obo/MONDO_0005550 |
T4 | 278-306 | Disease | denotes | respiratory tract infections | http://purl.obolibrary.org/obo/MONDO_0024355 |
T5 | 552-560 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T6 | 837-845 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T7 | 1051-1061 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
HP-phenotype
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 278-306 | Phenotype | denotes | respiratory tract infections | HP:0011947 |
T2 | 311-326 | Phenotype | denotes | neonatal sepsis | HP:0040187 |
NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 64-72 | OrganismTaxon | denotes | SARS-CoV | 694009 |
T2 | 80-88 | OrganismTaxon | denotes | Bacillus | 1386|55087 |
T4 | 320-326 | OrganismTaxon | denotes | sepsis | 137507 |
T5 | 911-924 | OrganismTaxon | denotes | Mycobacterium | 1763 |
T6 | 1051-1059 | OrganismTaxon | denotes | SARS-CoV | 694009 |
Anatomy-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 278-295 | Body_part | denotes | respiratory tract | http://purl.obolibrary.org/obo/UBERON_0000065|http://purl.obolibrary.org/obo/UBERON_0000072 |